Literature DB >> 12571439

Serum adenosine deaminase activity in women with pre-eclampsia.

Yoshio Yoneyama1, Rintaro Sawa, Shunji Suzuki, Yasuo Otsubo, Atsushi Miura, Yoshimitsu Kuwabara, Hiroshi Ishino, Yasuko Kiyokawa, Daisuke Doi, Koichi Yoneyama, Hajime Kobayashi, Tsutomu Araki.   

Abstract

The present study investigated serum adenosine deaminase (ADA) activity and the patterns of two ADA isoenzymes, ADA1 and ADA2, and to evaluate the possible role of cell-mediated immunity as causes of the changes in ADA activity in pre-eclampsia. We measured serum activities of total ADA, ADA1 and ADA2 in pre-eclampsia (n = 22) and normal pregnancy (n = 22). Peripheral blood monocyte counts and neopterin levels, reflecting the activation of the monocyte-macrophage cell system, were also measured. In pre-eclampsia, serum total ADA and ADA2 activities were significantly increased compared with normal pregnancy (p < 0.05), which were accompanied by increases in serum neopterin levels. These results suggest that increased total ADA activity reflects increases in ADA2 activity, which may be in part related to enhanced cell-mediated immunity during pre-eclampsia. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12571439     DOI: 10.1159/000067885

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  2 in total

1.  Changes in serum adenosine deaminase activity during normal pregnancy.

Authors:  Soo Jin Lee; Han Sung Hwang; Bit Na Rae Kim; Min A Kim; Jae Wook Lee; Yong Won Park; Young Han Kim
Journal:  J Korean Med Sci       Date:  2007-08       Impact factor: 2.153

Review 2.  Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming.

Authors:  Carlos Escudero; James M Roberts; Leslie Myatt; Igor Feoktistov
Journal:  Front Pharmacol       Date:  2014-06-05       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.